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Brief Definit ive Report
The innate immune system senses and responds 
to danger posed by different types of infection 
through recognition (by pattern recognition 
receptors) of conserved components of infectious 
agents (pathogen-associated molecular patterns 
[PAMPs]; Medzhitov, 2009). It can also sense 
and respond to other forms of danger, such as 
signs of cell stress or damage (damage-associated 
molecular patterns [DAMPs]), which may or 
may not be pathogen induced (Bianchi, 2007). 
PAMPs and DAMPs can trigger dendritic cell 
(DC) responses that help provide a context for 
activation of specific adaptive immune responses 
appropriate to the type of threat, such as dif-
ferent types of antibodies or cytotoxic T lym-
phocyte responses (Pulendran et al., 2010b). There 
is increasing evidence that certain inorganic 
and organic crystalline materials can also be per-
ceived as dangerous, but how these are sensed 
is little understood. However, it has been shown 
that alum crystals bind with extraordinary strength 
to the plasma membrane of DCs (Flach et al., 
2011) and are sensed independently of pattern 
recognition receptors, suggesting that physico-
chemical principles may be involved; the same 
is true for uric acid (DeFranco, 2008; Ng et al., 
2008) but not its analogue allopurinol, indi-
cating a remarkable selectivity in this process.
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There is currently no paradigm in immunology that enables an accurate prediction of how 
the immune system will respond to any given agent. Here we show that the immunological 
responses induced by members of a broad class of inorganic crystalline materials are con-
trolled purely by their physicochemical properties in a highly predictable manner. We show 
that structurally and chemically homogeneous layered double hydroxides (LDHs) can elicit 
diverse human dendritic cell responses in vitro. Using a systems vaccinology approach, we 
find that every measured response can be modeled using a subset of just three physical and 
chemical properties for all compounds tested. This correlation can be reduced to a simple 
linear equation that enables the immunological responses stimulated by newly synthesized 
LDHs to be predicted in advance from these three parameters alone. We also show that 
mouse antigen–specific antibody responses in vivo and human macrophage responses in vitro 
are controlled by the same properties, suggesting they may control diverse responses at 
both individual component and global levels of immunity. This study demonstrates that 
immunity can be determined purely by chemistry and opens the possibility of rational 
manipulation of immunity for therapeutic purposes.
© 2014 Williams et al. This article is distributed under the terms of an Attribution– 
Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
it is available under a Creative Commons License (Attribution–Noncommercial–
Share Alike 3.0 Unported license, as described at http://creativecommons.org/ 
licenses/by-nc-sa/3.0/).
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culture by assessing their ability to stimulate responses of 
human monocyte-derived DCs (Sallusto and Lanzavecchia, 
1994). We measured the capacity of DCs to secrete proin-
flammatory cytokines (IL-1, IL-6, and TNF), as well as 
cytokines that polarize Th1 responses (IL-12p70), maintain 
memory T cell responses (IL-15), and promote antiviral re-
sponses (IFN-2). We also investigated DC production of 
chemokines (IL-8, MIP-1, and MCP-1) and of membrane 
molecules involved in T cell activation (CD86), DC–T cell 
cross talk (CD40), and suppression of CD8 T cell proliferation 
(CD274). To study this systematically, we designed, synthe-
sized, and characterized a series of endotoxin-free LDHs, 
with systematic substitutions of metal cations and anions 
(Table S1). The LDHs were observed to comprise crystalline 
hexagonal platelets (Fig. 1). DCs were co-cultured with 
LDHs, and the cellular responses stimulated by each com-
pound were evaluated and compared with those elicited by 
the commercially available alums Imject and Alhydrogel. We 
found that individual LDHs stimulated distinct DC responses 
across many immunological outputs but with donor to donor 
variation. We therefore undertook a statistical repeated mea-
sures analysis, with a random effect to account for donor vari-
ability, and fitted a multilevel model to obtain estimates of the 
overall responses. Several compounds were found to stimulate 
robust DC responses, frequently much greater than the com-
mercially used Alhydrogel adjuvant (Fig. 2 and Tables S2 and S3). 
In Fig. 2 and subsequently, LDHs are denoted MxMy-X, 
where M and M are the metal cations in the LDH layers, x/y 
is the ratio of these ions, and X is the interlayer anion.
Through their capacity to elicit danger signals, alums have 
for many decades been incorporated into vaccines to stimu-
late high levels of protective antibodies against the antigens 
they contain (Marrack et al., 2009; Coffman et al., 2010). 
The alum used as adjuvants usually comprises aluminum 
oxyhydroxide (AlOOH) or aluminum hydroxyphosphate 
(Al(OH)x(PO4)y), but the materials are heterogeneous and 
poorly characterized. In contrast, layered double hydroxides 
(LDHs) are structurally and chemically homogeneous crystal-
line materials represented by the general chemical formula 
[Mz+1xM3+x(OH)2]p+(Xn)p/n·yH2O (see Fig. 1). In essence, 
the structure is a sandwich of positively charged mixed-metal 
hydroxide layers (containing both a trivalent [M3+] and either 
a monovalent [M+] or divalent [M2+] cation) with interlayers 
of negatively charged anions. LDHs can be synthesized in 
thousands of different chemical compositions with a large range 
of possible metal cations, varied ratios of (M+/M2+):M3+, 
and many different anions. Because alums are solid, ionic hy-
droxyl salts, we reasoned that LDHs may also elicit immuno-
logical responses; if so, the versatility of these materials would 
enable us to explore the impact of systematic chemical sub-
stitutions on the types of immunity induced.
RESULTS AND DISCUSSION
Chemically different LDHs stimulate diverse  
human DC responses in vitro
Because alum adjuvants act on DCs, at least in vivo (Kool 
et al., 2008a,b; Marrack et al., 2009; McKee et al., 2009), we 
initially evaluated the immunological properties of LDHs in 
Figure . Illustrations of typical LDHs and the systems vaccinology approach used in this study. (a–e) Transmission electron micrographs of 
LiAl2-CO3 (a), Mg2Al-NO3 (b), Mg2Fe-Cl (c), Imject alum (d), and Alhydrogel (e). Size data on the LDHs are in Table S1. (f) A schematic showing the systems 
vaccinology approach. To the left, the general LDH structure is depicted, showing the positively charged layers (yellow/blue/red circles) and interlayer 
anions (green circles), with a surrounding layer of water (top and bottom). The in vitro DCs and in vivo antibody responses stimulated by a series of LDHs 
were evaluated, and the datasets were then independently subjected to multivariate analysis, with the physicochemical properties of LDHs detailed in 
Table S4. All observed responses were highly correlated with the three key physicochemical properties indicated on the left side and conformed to the 
equation (Eq. 1) illustrated on the right side. This equation was then used to predict, de novo, the immunological (DC) responses stimulated by newly syn-
thesized LDHs from their respective physicochemical properties.
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the immunological responses. Surprisingly, this revealed that 
all in vitro human DC responses were very highly correlated 
with a linear combination of three LDH properties: the radius 
of the spherical M+ or M2+ metal cations; the distance be-
tween the LDH layers (interlayer spacing); and the zeta po-
tential, which defines the magnitude of the electrical charge 
at the interfacial double layer around the LDH particle (Fig. 1; 
Attwood, 2007). Correlation coefficients between this com-
bination and the observed responses ranged from 0.78 to 1.0, 
with one exception (IL-8) at 0.65. These correlations can be 
expressed by a simple linear equation:
DC responses are controlled purely by discrete 
physicochemical properties of LDHs
We then hypothesized that the varying immunological activi-
ties of different LDHs may be determined by their respective 
physicochemical characteristics. We therefore applied a regres-
sion model between all of the DC response datasets and the 
physicochemical properties of these LDHs obtained from 
published studies or measured directly (Table S4 a). Essentially, 
this approach considered that the physicochemical properties 
were causative of the immune responses and sought to find 
the closest fit between any given subset of properties and all 
Figure . Chemically different LDHs drive diverse DC responses in vitro. Human monocyte-derived DCs were cultured without or with the indicated 
LDH or commercial adjuvant preparation for a period of 24 h. The concentration of cytokines and chemokines in the supernatant was then determined 
using ELISA (IL-6 and TNF) or Luminex (others). Cell surface expression of co-stimulatory and co-inhibitory molecules was assessed by flow cytometry. MFI, 
mean fluorescence intensity. Error bars show one standard error. *, P < 0.05; and **, P < 0.01 versus cells alone. The number of individual experiments per-
formed for each response ranges from n = 6 to n = 22 and is given in Table S3. Each experiment contained at least three biological replicates.
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the responses elicited by the other, showing that the mod-
el’s predictions are composition specific. Because the predic-
tive power of our model is proportional to the size of the 
datasets, its accuracy should be increased by further cali-
bration across a wider series of LDHs with a broader range 
of properties.
The same physicochemical properties of LDHs control  
mouse antibody responses in vivo and may apply  
to other immunological responses
To explore the potential in vivo adjuvant activities of LDHs, 
we next evaluated the capacity of some of our compounds to 
elicit antibody responses in C57BL/6 mice, based on a vacci-
nation protocol to study adjuvant-driven responses against 
the model antigen OVA. Mice were primed i.p. with OVA 
admixed with each LDH, or alum, and boosted i.p. with solu-
ble OVA 1 wk later (Eisenbarth et al., 2008; Kool et al., 
2008b). Because this leads to primary antigen presentation in 
the mediastinal lymph nodes, which also drain the lungs, we 
then challenged the mice with a final, intranasal boost of 
soluble OVA 1 wk later. The resultant data confirmed that 
chemically different LDHs can elicit in vivo antibody re-
sponses that are at least as potent as those of the alums tested 
(Fig. 4 and Tables S7 and S8). Notably, vaccination with alum 
adjuvants resulted in OVA-specific IgG1 and IgE antibody 
production alone, reflective of a Th2-dominated response as 
expected, whereas some LDH compounds (e.g., Mg2Fe-CO3) 
	 ln .response A B C Pi i
i
i
= +
=
=
∑
1
3
	 (1)
In this equation, A, B, and Ci are coefficients for any given 
immunological response, and Pi is the value of each respective 
physicochemical property. (Values for LDH properties, which 
were standardized to ensure equal variance, and the coefficients 
are shown in Tables S4 b and S5.)
DC responses to newly synthesized LDHs can be  
accurately predicted simply from knowledge  
of their physicochemical properties
We next investigated the model’s ability to predict a priori the 
immunological properties of newly synthesized LDHs, using 
the robust and relatively high-throughput DC assays we had 
previously used. We synthesized two new LDH compounds, 
LiAl2-NO3 and Mg2Al-Cl (Table S1), and made blind pre-
dictions of the multiple (n = 12) DC responses they might 
induce based purely on their physicochemical properties. We 
found the correlation between predicted and actual observed 
responses to be remarkably high, with a median coefficient of 
variation of 5.14% (Fig. 3 and Table S6). We observed that 
22 of the 24 predicted values fell within the 95% confidence 
intervals (CIs); the probability of this occurring by chance is 
P < 0.0002. Conversely, just 14 out of 24 predicted values for 
responses elicited by one compound fall within the CIs for 
Figure . Multiple DC responses induced by newly synthesized LDHs can be predicted with a high degree of accuracy. (a) DC responses to 
LiAl2-NO3 and Mg2Al-Cl were assessed as in Fig. 2. Error bars show one standard error. **, P < 0.01 versus cells alone. Four independent experiments 
were performed, each with three or four biological replicates. (b and c) DC responses to LiAl2-NO3 and Mg2Al-Cl were predicted with Eq. 1 following 
calibration of the model using data from Fig. 2. In b, the mean and 95% CIs for the measured responses are indicated (diamonds and short horizontal 
lines) with the predicted value (triangles) immediately below. In c, observed ln responses are shown along a straight line of gradient 1, and the pre-
dicted ln responses as squares on the same plot.
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of systematically changing particle dose, size, and/or mor-
phology (Hu and O’Hare, 2005) on immunological responses. 
The regression model we developed (Fig. 1) derives from a 
systems vaccinology approach (Plotkin, 2008; Pulendran et al., 
2010a; Pulendran and Ahmed, 2011; Nakaya and Pulendran, 
2012), one aspiration of which has been to predict which ma-
terials will act as potent adjuvants to the immune system. Until 
now, lack of systematically variable adjuvants has made this 
impossible to achieve. In contrast, our chemical–immunology 
rule enables accurate prediction of the multiple DC, and po-
tentially other, responses that can be induced by any given 
LDH, the first time such an approach has been possible for 
any material. Ultimately, advances in computational chemis-
try should permit pure in silico screening of vast numbers of 
LDHs to select those with the most desirable properties. Hence 
our findings may comprise a paradigm shift in vaccinology by 
enabling the selection and synthesis of designer adjuvants that 
can be incorporated into bespoke vaccines, tailored for use in 
different disease settings.
MATERIALS AND METHODS
Synthesis and characterization of LDHs. LDHs were synthesized 
according to previously reported protocols (Khan et al., 2009). LiAl2-Cl and 
LiAl2-NO3 were prepared by the direct reaction of LiCl or LiNO3 with 
gibbsite. Mg2Al-NO3, Mg2Al-Cl, Mg2Fe-Cl, Mg2Fe-NO3, Ca2Al-Cl, and 
Ca2Al-NO3 were generated via a coprecipitation synthesis. LiAl2-CO3, 
Mg2Al-CO3, and Mg2Fe-CO3 were produced by reaction of the nitrate- or 
chloride-containing LDHs with an excess of sodium carbonate. Endotoxin 
was not detectable in any compound by Limulus amebocyte assay. Character-
ization was performed by x-ray diffraction, infrared spectroscopy, elemental 
microanalysis, and dynamic light-scattering measurements. The positions of 
the 00l reflections in diffraction patterns were used to calculate the interlayer 
stimulated production of OVA-specific IgG2c antibodies, 
indicative of a Th1-polarized response (Gavin et al., 2006; 
Eisenbarth et al., 2008). We then applied our regression model 
(above) to all of these in vivo antibody datasets and found 
that these, too, were very highly correlated with the same 
subset of LDH properties as above, conforming to Eq. 1. 
(Values for the properties and coefficients are shown in 
Tables S4 and S9.)
Finally, we have investigated the capacity of LDHs to 
induce human macrophage responses in vitro. Our initial data 
indicate that proinflammatory responses of human monocyte-
derived macrophages and dermal macrophages are highly 
correlated with the same LDH properties as above, also con-
forming to Eq. 1 (Table S10). Together, our findings suggest 
that the same “chemical–immunology rule” for these materi-
als may apply at other levels of immunity, such as T cell re-
sponses. In the latter context, we also have preliminary data 
suggesting that certain LDHs, notably Mg2Al-NO3 and 
Mg2Al-CO3, can elicit expansion of mouse OVA-specific ef-
fector CD8+ T cells in vivo (not depicted), and the former 
compound has been reported to elicit cytotoxic T lympho-
cytes in vivo (Li et al., 2011).
This study suggests a highly discriminatory mode for 
the sensing of crystalline materials by the immune system. 
Whether this is caused by the capacity of the plasma mem-
brane of DCs to act as a general sensor for solid structures 
(Flach et al., 2011), the regulated production of DAMPs, or 
other mechanisms (Dostert et al., 2008; Hornung et al., 2008) 
is under investigation; so too is the nature of the interaction 
between LDHs and DCs (e.g., phagocytosis) and the impact 
Figure . Chemically different LDHs have distinct adjuvant activities in vivo. Mice were immunized i.p. with 10 µg OVA admixed with 1 mg LDH, 
Alhydrogel, or Imject alum and boosted i.p. 10 d later with 10 µg OVA alone. Control mice were given the booster treatment only. (a) 7 d after boost, mice 
were bled via the tail vein, and serum levels of OVA-specific antibody isotypes were measured by ELISA. (b) Starting 1 wk later, the prime-boosted mice 
were challenged on three consecutive days with a 1% OVA aerosol. 1 d after the final challenge, ELISA was used to measure serum levels of OVA-specific 
antibody isotypes. Antibody titers are shown as OD450, as assessed by ELISA. Error bars depict one standard error. **, P < 0.01 via pairwise comparisons 
versus OVA alone. Data are from two independent experiments, each with at least five mice per group.
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properties were investigated, and the correlation coefficients were calculated, 
along with their associated p-values. The subset [ionic radius of M+ or M2+, 
interlayer spacing, and zeta potential] consistently produced the smallest 
p-values and very high correlations across all response types (median = 
0.863), all of which were statistically significant; note that all p-values for this 
subset were <0.025 (with a correlation of >0.6075). It should be noted that 
the physicochemical properties are often internally correlated with one an-
other, so the immune responses were correlated with several subsets of prop-
erties. The selected subset was chosen because it gave the highest correlations 
and lowest p-values. This resulted in the formula
	 ln ,response A B C Pi i
i
i
= +
=
=
∑
1
3 	 (1)
where the Ci values were calculated to maximize the correlation between 
the properties and the mean responses. The constants A and B were then 
determined by treating the relationship as one of cause and effect, in other 
words to regard the LDH properties as responsible for the responses; 
thus, A and B were obtained as regression coefficients. Values for the coeffi-
cients A, B, and Ci for the respective immunological datasets are shown in 
Tables S5, S9, and S10 c.
A priori predictions of the responses to newly synthesized LDHs 
were calculated using the formula in Eq. 1 with the values for A, B, and Ci 
determined from experiments previously undertaken with other LDHs. To 
obtain a conservative estimate for the likelihood of the prediction accuracy 
being attributable to chance, we first calculated the full range of estimated 
mean ln response across all compounds, then determined the mean 95% CI 
width and divided this by the range to give the largest plausible upper bound 
to the proportion of the range covered by the CI. The mean of this propor-
tion across all DC responses was then taken as an over-conservative estimate 
of the probability of a single prediction falling within the 95% CI by chance. 
This was 0.6272, and therefore the overall probability of the accuracy of 
prediction observed being caused by chance (22 of 24 responses within the 
95% CI) is 0.00023.
Online supplemental material. Table S1 shows chemical details and size 
data for the LDHs used in this study. Tables S2 and S3, included in a separate 
PDF file, respectively, show actual and ln values and significance data for 
DC responses to LDHs and alums. Table S4, included in a separate PDF file, 
shows the actual (a) and standardized (b) physicochemical properties of the 
LDHs used in this study. Table S5, included in a separate PDF file, shows 
coefficients for DC responses according to Eq. 1. Table S6, included in a 
separate PDF file, shows the actual DC response to newly synthesized LDHs 
and that predicted from Eq. 1. Tables S7, S8, and S9, included in a separate 
PDF file, respectively, show the actual and ln values, significance data, and 
coefficients according to Eq. 1 for mouse OVA-specific antibody responses to 
LDHs and alums. Table S10, included in a separate PDF file, shows the actual 
and ln values (a), significance data (b), and coefficients (c) according to Eq. 1 
for macrophage responses to LDHs and alums. Online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20131768/DC1.
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spacing (the distance between the LDH layers). The zeta potential was 
measured for 10 mg/ml solutions of the LDHs in phosphate buffered saline, 
initial pH 7.2. The M+ or M2+ ionic radius was taken from the literature 
(Lide, 2000).
Immunological assays in vitro. Human monocyte-derived DCs were 
generated according to standard procedures (Sallusto and Lanzavecchia, 1994). 
Monocytes were isolated from human blood products (Buffy coats or leuko-
cyte cones) using density gradient centrifugation (Lymphoprep; Axis-Shield) 
followed by negative selection (EasySep Human Monocyte Enrichment kit; 
STEMCELL Technologies) and cultured for 6 d in complete RPMI supple-
mented with recombinant human (rh) GM-CSF and rhIL-4 (DC-RPMI). 
Cytokines were supplied by Gentaur Belgium BVBA or PeproTech. On day 6, 
DCs were suspended in DC-RPMI at 5 × 105 cells/ml and transferred to 
flat-bottomed, 96-well plates with 200 µl of cells per well. DCs were then 
co-cultured for 24 h with the LDHs or commercial alums (Alhydrogel 
[Sigma-Aldrich] and Imject alum [Thermo Fisher Scientific]) at 476 µg/ml 
final concentration. The expression of surface proteins by the DCs was mea-
sured by flow cytometry (FACSCanto [BD], with analysis using FlowJo soft-
ware). Cytokines were measured either by ELISA (Insight Bioscience Ltd.) or 
by Luminex technology (EMD Millipore) according to the manufacturers’ in-
structions. Macrophages were generated from monocytes isolated in an identi-
cal process to that used for generating DCs. Subsequently, monocytes at 5 × 105 
cells/ml were seeded in 96-well plates (200 µl/well) and cultured for 6 d with 
10 ng/ml rhM-CSF alone to generate macrophages (Becker et al., 1987) or 
with 10 ng/ml rhM-CSF, 10 ng/ml rhIL-10, and 10 U/ml rhGM-CSF to pre-
pare dermal macrophages (Kwan et al., 2008). Cells were co-cultured with 
LDHs or commercial alums as above, and cytokine production was measured 
by ELISA in accordance with the manufacturer’s instructions.
Immunological assays in vivo. For antibody assays, C57BL/6 mice 
(Harlan Laboratories) were immunized with the model antigen OVA 
(Worthington Biochemical Corporation) with or without each LDH com-
pound or commercial Imject alum (Thermo Fisher Scientific) as a potential 
adjuvant (n ≥ 5 per experimental group). Mice were sensitized i.p. with 500 µl 
OVA at 20 µg/ml admixed with 2 mg/ml LDH (a dose of 10 µg OVA and 
1 mg LDH/mouse). 7 d later they were boosted i.p. with 10 µg OVA alone. 
1 wk later (day 14) mice were bled via the tail vein, and the serum levels of 
OVA-specific IgG1, IgE, and IgG2c were measured by ELISA (eBioscience). 
The prime-boosted mice were then challenged with a 1% OVA aerosol for 
30 min on each of days 17, 18, and 19. On day 20 the mice were sacrificed 
with an overdose of Avertin. Blood was collected to determine the serum 
levels of OVA-specific IgE, IgG1, and IgG2c antibodies as above. All experi-
ments were approved by the Ethical Committee for Animal Experimenta-
tion, Faculty of Science, University of Ghent and VIV site Ardoyen; site 
license number LA1400091.
Statistical analysis. The observational data comprised repeated measures of 
immunological responses from several experiments. Therefore, to obtain esti-
mates of the mean response for each compound, it was necessary to fit a se-
ries of two-level linear mixed-effects models. This was done using the lme 
function from the nlme library in the R statistical package with experiment 
ID as the second level. To obtain normally distributed residuals and stability 
of variance, the responses were log-transformed, after which all of the usual 
diagnostic tests proved to be entirely satisfactory. This analysis provided the 
estimates of the mean responses given in Tables S2 (shown in Fig. 2), S7 (shown 
in Fig. 4), and S10 a and the p-values detailed in Tables S3, S8, and S10 b.
Investigation of possible relationships between the immune responses 
and the physicochemical properties of the LDHs given in Table S4 was per-
formed by computing the canonical correlation coefficients between subsets 
of the properties and the set of mean responses for each adjuvant. Because 
the magnitude of the different “as-measured” properties varied considerably 
(Table S4 a), the properties were first standardized to have mean 0 and unit 
variance (Table S4 b). This was performed to ensure that each property had 
equal weighting at the start of analysis. All possible subsets of three or four 
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